• Je něco špatně v tomto záznamu ?

Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K870

J. Zdarova Karasova, J. Kassa, V. Hepnarova, J. Pejchal, L. Junova, R. Andrys, D. Malinak, P. Bzonek, Z. Kohoutova, K. Musilek

. 2022 ; 167 (-) : 113236. [pub] 20220620

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024578

Oxime reactivators are causal antidotes for organophosphate intoxication. Herein, the toxicity, pharmacokinetics, and reactivation effectiveness of o-chlorinated bispyridinium oxime K870 are reported. Oxime K870 was found to have a safe profile at a dose of 30 mg/kg in rats. It exhibited rapid absorption and renal clearance similar to those of other charged oximes after intramuscular administration. Its isoxazole-pyridinium degradation product was identified in vivo. Although it showed some improvement in brain targeting, it was nevertheless rapidly effluxed from the central nervous system. Its reactivation effectiveness was evaluated in rats and mice intoxicated with sarin, tabun, VX, and paraoxon and compared with pralidoxime and asoxime. K870 was found to be less effective in reversing tabun poisoning compared to its parent unchlorinated oxime K203. However, K870 efficiently reactivated blood acetylcholinesterase for all tested organophosphates in rats. In addition, K870 significantly protected against intoxication by all tested organophosphates in mice. For these reasons, oxime K870 seems to have a broader reactivation spectrum against multiple organophosphates. It seems important to properly modulate the oximate forming properties (pKa) to obtain more versatile oxime reactivators.

000      
00000naa a2200000 a 4500
001      
bmc22024578
003      
CZ-PrNML
005      
20221101090254.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.fct.2022.113236 $2 doi
035    __
$a (PubMed)35738326
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Zdarova Karasova, Jana $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital, Hradec Kralove, Czech Republic. Electronic address: zdarovakarasovaj@unob.cz
245    10
$a Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K870 / $c J. Zdarova Karasova, J. Kassa, V. Hepnarova, J. Pejchal, L. Junova, R. Andrys, D. Malinak, P. Bzonek, Z. Kohoutova, K. Musilek
520    9_
$a Oxime reactivators are causal antidotes for organophosphate intoxication. Herein, the toxicity, pharmacokinetics, and reactivation effectiveness of o-chlorinated bispyridinium oxime K870 are reported. Oxime K870 was found to have a safe profile at a dose of 30 mg/kg in rats. It exhibited rapid absorption and renal clearance similar to those of other charged oximes after intramuscular administration. Its isoxazole-pyridinium degradation product was identified in vivo. Although it showed some improvement in brain targeting, it was nevertheless rapidly effluxed from the central nervous system. Its reactivation effectiveness was evaluated in rats and mice intoxicated with sarin, tabun, VX, and paraoxon and compared with pralidoxime and asoxime. K870 was found to be less effective in reversing tabun poisoning compared to its parent unchlorinated oxime K203. However, K870 efficiently reactivated blood acetylcholinesterase for all tested organophosphates in rats. In addition, K870 significantly protected against intoxication by all tested organophosphates in mice. For these reasons, oxime K870 seems to have a broader reactivation spectrum against multiple organophosphates. It seems important to properly modulate the oximate forming properties (pKa) to obtain more versatile oxime reactivators.
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a zvířata $7 D000818
650    _2
$a antidota $7 D000931
650    _2
$a cholinesterasové inhibitory $x metabolismus $x toxicita $7 D002800
650    12
$a reaktivátory cholinesterázy $x terapeutické užití $7 D002801
650    _2
$a myši $7 D051379
650    _2
$a organofosfáty $7 D010755
650    12
$a oximy $7 D010091
650    _2
$a pyridinové sloučeniny $x toxicita $7 D011726
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kassa, Jiri $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Hepnarova, Vendula $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Pejchal, Jaroslav $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Junova, Lucie $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Andrys, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Malinak, David $u Biomedical Research Center, University Hospital, Hradec Kralove, Czech Republic; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Bzonek, Petr $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Kohoutová, Zuzana $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic $7 xx0278041
700    1_
$a Musilek, Kamil $u Biomedical Research Center, University Hospital, Hradec Kralove, Czech Republic; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Electronic address: kamil.musilek@uhk.cz
773    0_
$w MED00001825 $t Food and chemical toxicology $x 1873-6351 $g Roč. 167, č. - (2022), s. 113236
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35738326 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221101090250 $b ABA008
999    __
$a ok $b bmc $g 1854351 $s 1175868
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 167 $c - $d 113236 $e 20220620 $i 1873-6351 $m Food and chemical toxicology $n Food Chem Toxicol $x MED00001825
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...